Objectives: To improve the existing animal models (mice, rats, and hamsters) for radiotherapy-induced oral mucositis (RTOM), thereby establishing a radiotherapy-induced glossitis (RTG) Sprague-Dawley (SD) rat model. Study Design: A lead device was designed to limit radiation exposure to a 1×1 cm2 area of a rat's dorsal anterior tongue with a single 30Gy of X-ray radiation. The general conditions of the irradiated rats, such as body-weight and behavior, were observed. The oral mucositis index (OMI) of the RTG rats were measured daily. Histological changes of the irradiated tongue tissues were assayed by H&E staining. Results and Conclusion: No significant changes were clinically observed 3 to 4 days after irradiation. At 5 to 6 day, punctuation and confluenced redness of the mucosa were observed. The small blood vessels became more extensive, engorged, thin vessel walls. More infiltrating cells were observable, necrosis and exfoliation of the squamous cells appeared, and the formation of an ulcerative lesion could be observed. Seven to 15 days, the exfoliated epithelial layer was observed to have formed an ulcerative lesion, then aggravated ulcerative lesions consisting of pseudomembranous filament exudates could be observed. The structure of the epithelium had become completely disintegrated, forming deep, microscopic ulcerative lesions. Twenty-one days, the periphery of the ulcer was observed to have begun to heal, and granulation tissue could be observed at the bottom of the ulceration. At 35 days after irradiation, the epithelial structure presented again, but the epithelium was very thin. An RTG animal model was successfully established in SD rats, which provides a new research platform for the study of RTOM pathogenesis.
Introduction
Radiotherapy-induced oral mucositis (RTOM) is one of the most debilitating side effects of radiotherapy, and threatens the effectiveness of antitumor therapy because it limits the dose of applied radiation, causes malnutrition and weight loss, decreases the patient's quality of life, increases the cost of healthcare, prolongs the length of in-patient stays, and demands more medical and social resources (1) . Therefore, RTOM is the primary dose-limiting factor in head and neck malignancy radiotherapy, which is a problem that requires immediate resolution (2, 3) . Presently, only one agent, Palifermin (recombinant keratinocyte growth factor-1) (4), is approved for the treatment of cancer treatment-related oral mucositis, although sev¬eral others are at various stages of development (5-10). The pathogenesis of RTOM is not fully understood and prophylactic and/or therapeutic strategies should be evaluated with further investigation (11) . Several animal models have been used to investigate RTOM. In the 1980s, mouse lip (12, 13) and mouse ventral tongue mucosa (14) were used as animal models for RTOM, whereas in the 1990s, the hamster cheek pouch model was developed (15) . Dose response curves for the appearance of gross ulceration in these tissues following irradiation with single and fractionated regimens have been obtained (14) (15) (16) (17) (18) , identifying several flaws in the aforementioned animal models. The first flaw in these models is the high animal death rate, particularly the mice used in the mouse model. When the mouse snout is irradiated in the mouse model, the brain is inevitably also irradiated, frequently resulting in death of the experimental animals. A second flaw includes the use of multiple instances of anesthesia, irradiation, and uncontrollable fractional irradiation, such that homogenous tissue irradiation is difficult to obtain, sometimes resulting in animal death. A third flaw of the aforementioned models is that the usable quantity of irradiated mouse oral tissue is small, limiting extensive analysis. A final flaw in the aforementioned animal models is that although buccal pouch eversion provides sufficient oral tissue for investigation and is easily isolated from the rest of the body during radiation treatment, the hamster buccal pouch is an immune-privileged site, and cannot therefore provide an accurate immune response reaction. The present study intends to duplicate and further improve existing RTOM animal models by only exposing anterior dorsal tongue mucosal tissue to metered, single 30-Gy doses of X-rays and to develop an animal model that effectively represents radiotherapy-induced glossitis (RTG) in SD rats. Furthermore, this study intends to provide a new research platform to investigate prophylactic and therapeutic methods for RTOM. The rats were housed in polycarbonate cages with six rats per cage, and were provided free access to standard rat food and filtered city tap water from standard perspex drinking bottles. The rats were housed with a 12-hr light/12-hr dark cycle (the light phase ranged from 06:00 to 18:00 at a lux of 150 to 300) in a room maintained at a temperature of 23±1 °C and humidity of 55±5% under specified pathogen-free conditions.
Materials and Methods

-Ethics
-Irradiation Protocol and Experimental Design
All of the rats used in this study were allowed to adapt to the housing conditions for two to three days prior to X-ray irradiation in order to mitigate adverse irradiation responses. The experimental rats were randomly divided into eight groups of six, with one group as the control and the remaining seven as experimental groups. Prior to X-ray irradiation, each rat received an abdominal injection of 6 ml/kg of a 5% chloral hydrate solution. The 6 rats in the control group were shielded under a lead plate, whereas the 42 rats in the remaining seven experimental groups were irradiated with no protective shielding. Exclusive irradiation of each rat's anterior dorsal tongue was achieved by using a 2 mm-thick, cone-shaped lead shielding device that was specially designed and constructed in our laboratory. The tongue of every rat was guided through a notch in the lead device using forceps such that the anterior dorsal part of the tongue could be fixed to the outer surface of the lead device using adhesive tape. An accessory lead plate with a "u-shaped" notch was used to cover the tongue and limit the irradiated area to 10×10 mm2. These two lead plate layers ensured that the rest of the animal's body was shielded from radiation exposure (Fig. 1) . A deep X-ray machine, (type F34-I; Dong Fang, Beijing, China) using an acceleration voltage of 210 kV, working current of 12 mA, a target distance of 40 cm, an irradiation field of 10×15 cm2, a 4-mm aluminum filter system, and a delivered dosage of 100.75 cGY/min was used to irradiate the rats used in this study. The heads of six rats were placed in the same irradiation field during radiation exposure. Thirty Gray of radiation were delivered at one time to all of the experimental rats in a group at 09:00.
-Gross observation and data sampling frequency All rats were carefully monitored twice or four times daily throughout the experimentation period. Each rat was weighed at 08:00, had their feces inspected, and behavioral characteristics assessed daily. Two cotton threads were used to open the rat's oral cavity, the tongue was gently pushed back using a cotton ball, and digital images of the irradiated tongue tissue were taken using a Fuji digital camera (Model: E900) under a cold lamp source. Clinical record sheets were prepared according to observations of the exposed tongue. The dorsal tongue surface of each rat was evaluated using a previously developed method by Parkins [12] (Table 1) . A. An anesthetized rat. B. The 2 mm-thick, cone-shaped lead device designed by our research team. C, D, E, and F. The tongue of every rat was guided through a notch in the lead device using forceps such that the anterior dorsal part of the tongue could be fixed to the outer surface of the lead device using adhesive tape. An accessory lead plate with a "u-shaped" notch was used to cover the tongue and limit the irradiated area to 10×10 mm2. These two lead plate layers ensured that the rest of the animal's body was shielded from radiation exposure. G. The anterior dorsal tongue after irradiation.
Score
Description 0 Normal 0. OMI were expressed as mean ± SD.
-Histology (H&E staining) Three, 5, 8, 14, 21, 28, and 35 days after irradiation, six rats randomly selected from each group were exsanguinated via a cardiac puncture and then killed via cervical dislocation. Tongue specimens were obtained by cutting the tongue root, which were then bathed in a neutral buffered 10% concentrated formalin solution, paraffin embedded, and excised for hematoxylin and eosin staining. Histological assessment was conducted using optical microscopy.
Results
-Survival rate
No rats accidently died during the 6-week experimental period.
-Anterior dorsal tongue mucosal macroscopical and histological analysis
Four days after irradiation, no significant changes in the irradiated mucosae were observed (Fig.2.B ). Five to 6 days after irradiation, reddening and red spots were observed in the anterior tongue mucosae of the irradiated rats ( Fig.2.C left) . The histology in that section showed that the small blood vessels became more extensive, engorged, thin vessel walls. More infiltrating cells were observable, necrosis and exfoliation of the squamous cells appeared, and the formation of an ulcerative lesion could be observed (Fig.2.C right) . Seven to 8 days after irradiation, the tongue mucosa of each irradiated rat exhibited discernible ulcers (Fig.2.D left) . Nine to 14 days after irradiation, the previously observed ulcers fused together into a laminated form resulting in the formation of ulcers with large surface areas ( Fig.2 .E left). Fifteen to 17 days after irradiation, mitigated laminated-form ulcers could be observed. The structure of the epithelium had become completely disintegrated, forming deep, microscopic ulcerative lesions (Fig.2 .D right, 2.E right). Eighteen days after irradiation, a consistent and gradual ulcer reduction was observed. Twenty days after irradiation, the irradiated anterior tongue mucosa was generally healed (Fig.2.F left, 2 .G left), and granulation tissue could be observed at the bottom of the ulceration (Fig.2.F right, 2 .G right). It was observed to be completely healed 15 days later (Fig.2.H left) , with no visible differences in comparison to the control mucosae ( Fig.2.A left) , but the epithelium was very thin (Fig.2.H right) .
-Mucositis Index Based on the evaluations described above, a typical mucositis curve was obtained following the single 30-Gy irradiation regime (Fig. 3) .
Discussion
Tongue ulceration represents the mucosal damage seen in high-grade oral mucositis in cancer patients (1, 5) . The present study was designed to identify all possible alterations in tongue mucosae due to locally applied irradiation. Radiotherapy-induced oral mucositis animal models have been described previously (12) (13) (14) (15) (16) (17) (18) ; however, these models have frequently used mice, and it is technically difficult to produce definitive irradiation doses in mouse buccal or gingival mucosa due to the small size of the typical mouse. Therefore, we have selected the tongue as a more appropriate irradiation site. Furthermore, an SD rat anterior tongue mucosal mucositis model was preferred for this study, since it provides the best reproducibility, adequate space for e353
References with links to Crossref -DOI sufficient tissue sampling, and definitive irradiation features, such as voltage, distance, and exclusive irradiation of the anterior tongue mucosae via appropriate shielding. Additionally, the dorsal surface of the tongue can be covered with keratinized epithelium and nonkeratinized epithelium and can adequately express the epithelium tissues of oral mucosae. In comparison to previous radiotherapy-induced oral mucositis animal models, the tongue can be easily observed on a daily schedule (5, 14, 19) . In this study, we designed a 2-mm-thick, cone-shaped lead device that limited irradiation to a 1×1 cm2 area of anterior dorsal tissue, while the remainder of the rat body was effectively shielded from radiation (see Fig.  1 for an illustration). In contrast, snout-only irradiation of mice in mouse models is not sufficiently specific as to obviate the ultimate cause of death of irradiated animals. In the present model, a single instance of anesthesia and irradiation was employed to mitigate the previously observed high rates of experimental animal death. No accidental animal death was observed in the rat model developed in this study, despite that the irradiation dose of 30 Gy used herein is identical to that used in previous reports (5) . The typical appearance and progression of oral mucositis were observed to occur at the local region of the anterior dorsal tongue of the irradiated rats, which appeared to be in a latent stage 1 to 4 days after irradiation, present gradual ulceration 5 to 14 days after irradiation, peak in ulcerification 15 to 20 days after irradiation, begin to gradually heal 15 days after irradiation, and be completely healed 35 days after irradiation. Most importantly, flash anesthesia was not needed for daily observation of the irradiated tissue when using the present model.
In preliminary studies, we demonstrated the correlation of radiation dosage to the degree of tongue mucosal damage and determined that a single fraction of high-level radiation at 30 Gy directly delivered to the rat anterior dorsal region reliably resulted in overt tongue mucosal ulceration that peaked 9 to 14 days after irradiation (data not shown). In order to assess the severity of mucositis in the mouse or hamster cheek pouch models, the animals typically need to be anesthetized and their buccal pouches everted [15] ; however, in the present model, it much more facile to directly observe the anterior and dorsal regions of the rats' tongues without the need of anesthesia. Taken together, the present model adequately describes the clinical features of severe oral mucositis and provides an easily observable area of ulceration.
Conclusion
The RTG model developed herein is a simple, but effective animal model that describes the pathogenesis of RTOM. This model was successfully established in SD rats, which provides a new research platform to investigate prophylactic and therapeutic methods of RTOM.
